共 12 条
- [1] Kukes V.G., Clinical Pharmacology [In Russian], (2006)
- [2] Tsuda K., Tsuda S., Masuyama Y., Goldstein M., Alterations in catecholamine release in the central nervous system of spontaneously hypertensive rats, Jpn. Heart J., 32, 5, pp. 701-709, (1991)
- [3] Paxinos G., Watson C., The Rat Brain in Stereotaxic Coordinates, (1997)
- [4] Buffalari D.M., Grace A.A., Noradrenergic modulation of basolateral amygdala neuronal activity: Opposing influences of α-2 and β receptor activation, Journal of Neuroscience, 27, 45, pp. 12358-12366, (2007)
- [5] DeBock F., Kurz J., Azad S.C., Parsons C.G., Hapfelmeier G., Zieglgansberger W., Rammes G., α <sub>2</sub>-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: Involvement of G <sub>i/o</sub>-protein-mediated modulation of Ca <sup>2+</sup>-channels and inwardly rectifying K <sup>+</sup>-channels in LTD, European Journal of Neuroscience, 17, 7, pp. 1411-1424, (2003)
- [6] Ji X.-H., Ji J.-Z., Zhang H., Li B.-M., Stimulation of α <sub>2</sub>-adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat, Neuropsychopharmacology, 33, 9, pp. 2263-2271, (2008)
- [7] Grasso C., Li Volsi G., Licata F., Ciranna L., Santangelo F., Aminergic control of neuronal firing rate in thalamic motor nuclei of the rat, Archives Italiennes de Biologie, 144, 3-4, pp. 173-196, (2006)
- [8] Langer S.Z., Presynaptic regulation of the release of catecholamines, Pharmacol. Rev., 32, 4, pp. 337-362, (1980)
- [9] Philipp M., Brede M., Hein L., Physiological significance of α <sub>2</sub>-adrenergic receptor subtype diversity: One receptor is not enough, American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 283, 2, (2002)
- [10] Reid J.L., Panfilov V., MacPhee G., Elliott H.L., Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol, Ann. N.Y. Acad. Sci., 763, pp. 673-678, (1995)